L3MBTL1 and cancer: \documentclass[12pt]{minimal}\usepackage{amsmath}\usepackage{wasysym}\usepackage{amsfonts}\usepackage{amssymb}\usepackage{amsbsy}\usepackage{upgreek}\usepackage{mathrsfs}\setlength{\oddsidemargin}{-69pt}\begin{document}}{}$\bullet $\end{document} Master regulators such as L3MBTL1, SALL2, BTRC, PRKCZ, KAT2A and SMARCC2 are positively active for the immune-silent cancer phenotype in pan-cancer settings.